SRI-35241
SRI-35241 is a thrombospondin TSP-1 inhibitor with a pIC50 of 8.12 nM against human targets. SRI-35241 inhibits the binding of TSP-1 to latent transforming growth factor-β-associated peptide (LAP) and blocks the activation of TGF-β. SRI-35241 shows a certain time-dependent property, with a plasma half-life of 1.8 h after intravenous administration. SRI-35241 can be used for the research of multiple myeloma and fibrotic diseases.
For research use only. We do not sell to patients.
- CAS No.: 2307429-54-3
- Formula: C11H22N4O3
- Molecular Weight:258.32
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
SRI-35241 inhibits thrombospondin 1-mediated TGF-β activation in human myeloma cells with a pIC50 of 8.12 nM[1].
SRI-35241 (10 nM; 10 min) inhibits binding of recombinant LAP to recombinant thrombospondin 1 type 1 repeats (P123) by ~85% at 10 nM in an indirect binding ELISA assay[1].
SRI-35241 has a half-life of 170 min in rat liver microsomes and >300 min in human liver microsomes, indicating improved microsomal stability compared to the parent compound[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2307429-54-3
-
Molecular Weight 258.32
-
Formula C11H22N4O3
-
SMILES
NC(C(C)(C)NC([C@@H](NC(C)=O)CCCN)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)